Biggest News Aggregation in the World
๐Ÿ“ฐ Looking Statement News

Page 10 - Looking Statement News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Looking Statement. Real-time updates on events, politics, business and more.

Ceridian to Acquire eloomi, a Market-Leading Learning and Development Platform

Powerful new people development capabilities to equip Dayforce™ customers with optimized training and development programs for the extended workforceTORONTO and MINNEAPOLIS, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Ceridian (NYSE: CDAY; TSX: CDAY), a global leader in human capital management (HCM) technology, today announced it has entered into a definitive agreement to acquire eloomi, a leading learning experience platform software provider based in Copenhagen, Denmark, and Orlando, Florida. Th...
United States Matt Wells Claus Johansen Joe Korngiebel Teri Murphy Pm Hotels
Source: yahoo.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

FDA Approves Merck's KEYTRUDA (pembrolizumab) Plus Chemoradiotherapy as Treatment for Patients With FIGO 2014 Stage III-IVA Cervical Cancer

12.01.2024 - Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, Merckโ€™s anti-PD-1 therapy, in combination with chemoradiotherapy (CRT) for the treatment of ...
United States Gursel Aktan Foundation Inc Statement Of Merck Co Inc European Network For Gynaecological Oncological Trial Merck Patient Support Program

FDA Approves Merck's KEYTRUDA® (pembrolizumab) Plus Chemoradiotherapy as Treatment for Patients With FIGO 2014 Stage III-IVA Cervical Cancer -January 12, 2024 at 05:31 pm EST

KEYTRUDA is the first and only anti-PD-1 therapy approved in combination with chemoradiotherapy for these patients Approval marks third FDA-approved indication for KEYTRUDA in cervical cancer and...
United States Gursel Aktan Merck Co Inc European Network For Gynaecological Oncological Trial Patient Support Program Merck Access Program

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science